Cargando…

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a

BACKGROUD: The purpose of this study was to elucidate the regulation of programmed death ligand 1 (PDL1), lactate dehydrogenase A (LDHA) and miR-34a in triple negative breast cancer (TNBC) and to explore the function and mechanism of PDL1 and LDHA as competitive endogenous RNAs (ceRNAs) in TNBC via...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiaojia, Xie, Xinhua, Wang, Hua, Xiao, Xiangsheng, Yang, Lu, Tian, Zhi, Guo, Xiaofang, Zhang, Lijuan, Tang, Hailin, Xie, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602941/ https://www.ncbi.nlm.nih.gov/pubmed/28915924 http://dx.doi.org/10.1186/s13046-017-0593-2

Ejemplares similares

circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: He, Rongfang, et al.
Publicado: (2017)

The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer
por: Xiao, Xiangsheng, et al.
Publicado: (2016)

circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma
por: Wang, JunFeng, et al.
Publicado: (2020)

Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells
por: Alfieri, Mariaevelina, et al.
Publicado: (2022)

Characterization of super‐enhancer‐associated functional lncRNAs acting as ceRNAs in ESCC
por: Wang, Qiu‐Yu, et al.
Publicado: (2020)

ce‐Subpathway: Identification of ceRNA‐mediated subpathways via joint power of ceRNAs and pathway topologies
por: Feng, Chenchen, et al.
Publicado: (2018)

Long Non‑Coding RNAs Regulate Inflammation in Diabetic Peripheral Neuropathy by Acting as ceRNAs Targeting miR-146a-5p
por: Feng, Yonghao, et al.
Publicado: (2020)

Roles of ncRNAs as ceRNAs in Gastric Cancer
por: Ye, Junhong, et al.
Publicado: (2021)

Therapeutic prospects of ceRNAs in COVID-19
por: Liu, Lin, et al.
Publicado: (2022)

circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

Interactions between Distant ceRNAs in Regulatory Networks
por: Nitzan, Mor, et al.
Publicado: (2014)

Extensive ceRNA–ceRNA interaction networks mediated by miRNAs regulate development in multiple rhesus tissues
por: Xu, Juan, et al.
Publicado: (2016)

Progress on the Regulation of Ruminant Milk Fat by Noncoding RNAs and ceRNAs
por: Lu, QinYue, et al.
Publicado: (2021)

Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer
por: Yuan, Naijun, et al.
Publicado: (2017)

Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks
por: Hu, Rui, et al.
Publicado: (2021)

mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
por: Liu, Peng, et al.
Publicado: (2016)

LncRNA as ceRNAs may be involved in lactation process
por: Yu, Shuai, et al.
Publicado: (2017)

The Roles of ceRNAs-Mediated Autophagy in Cancer Chemoresistance and Metastasis
por: Zhang, Huilin, et al.
Publicado: (2020)

The Functional Characterization of Epigenetically Related lncRNAs Involved in Dysregulated CeRNA–CeRNA Networks Across Eight Cancer Types
por: Xu, Dahua, et al.
Publicado: (2021)

Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation
por: Kartha, Reena V., et al.
Publicado: (2014)

Circular RNAs function as ceRNAs to regulate and control human cancer progression
por: Zhong, Yaxian, et al.
Publicado: (2018)

Construction and dissection of the ceRNA-ceRNA network reveals critical modules in depression
por: Lang, Yan, et al.
Publicado: (2019)

miRTissue (ce): extending miRTissue web service with the analysis of ceRNA-ceRNA interactions
por: Fiannaca, Antonino, et al.
Publicado: (2020)

PDL1 Regulation by p53 via miR-34
por: Cortez, Maria Angelica, et al.
Publicado: (2015)

Coronary artery disease: differential expression of ceRNAs and interaction analyses
por: Kang, Sheng, et al.
Publicado: (2021)

ceRNAs in Cancer: Mechanism and Functions in a Comprehensive Regulatory Network
por: Yang, Ni, et al.
Publicado: (2021)

The ceRNA Crosstalk between mRNAs and lncRNAs in Diabetes Myocardial Infarction
por: Zhou, Yun, et al.
Publicado: (2022)

MTDH promotes glioma invasion through regulating miR-130b-ceRNAs
por: Tong, Liping, et al.
Publicado: (2017)

Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p
por: Wang, Lu, et al.
Publicado: (2021)

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
por: Chen, Bo, et al.
Publicado: (2018)

Characterization of Dysregulated lncRNA-Associated ceRNA Network Reveals Novel lncRNAs With ceRNA Activity as Epigenetic Diagnostic Biomarkers for Osteoporosis Risk
por: Zhang, Meijie, et al.
Publicado: (2020)

LINC00511 promotes gastric cancer cell growth by acting as a ceRNA
por: Sun, Chong-Bing, et al.
Publicado: (2020)

The new ceRNA crosstalk between mRNAs and miRNAs in intervertebral disc degeneration
por: Li, Xingye, et al.
Publicado: (2022)

Two predicted models based on ceRNAs and immune cells in lung adenocarcinoma
por: Zhang, Miaomiao, et al.
Publicado: (2021)

Identifying Autophagy-Related lncRNAs and Potential ceRNA Networks in NAFLD
por: Cao, Ziyi, et al.
Publicado: (2022)

TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a
por: Yang, Bin, et al.
Publicado: (2018)

Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
por: Song, Xiang, et al.
Publicado: (2019)

The mRNA related ceRNA–ceRNA landscape and significance across 20 major cancer types
por: Xu, Juan, et al.
Publicado: (2015)

Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating miR-34a
por: Xiao, Xiangsheng, et al.
Publicado: (2014)

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c2rtkparejhknsq4141dinqj1c